The decision as to the choice of method for immunizing a large group of individuals against a communicalble disease should depend upon the following three considerations; namely, the nature and frequency of reactions, the degree and persistence of the resulting immunity, and, finally, the cost in materials and time. In our present study, the intradermal method of immunization against typhoid is compared with the subcutaneous method with the above factors in mind. Tuft, 6 ' '7 in 1931, first suggested the intradermal method to be the one of choice. During the past decade several authors7' 8, 10 have confirmed Tuft's work and the intmdermal method has also been used with apparent success in immunizing against scarlet fever7 and diphtheria.2 However, most of the immunologic studies were carried out after relatively short intervals following typhoid vaccnations and on groups in the older age range. It seemed desirable to study a younger group for at least one year.
Materid and methods Lederle's T.A.B. vaccine was used. This vaccine contains 1,000 million typhoid, 500 million paratyphoid A, and 500 million paratyphoid B organisms per cubic centimeter. Forty-four high-grade boys living in one cottage were chosen for the subcutaneous injections. They varied in age from 6 to 17, averaging about 10 years of age. They received three injections, 0.5 cc., 1.0 cc., and 1.0 cc., at weekly intervals. Forty-one girls, living in another cottage, ranging in age from 7 to 19 and also averaging about 10 years of age, were selected for the intradermal inoculations. These individuals received 0.05 cc., 0.1 cc., and 0.1 cc. at weekly intervals, respectively.
Blood was drawn from both groups after 50 days, 5 months, and 13 months, respectively, following the last injection. Using the rapid slide agglutination technic described by Welch and Stuart,1' the levels of the somatic "O" and the flagellar "H" agglutinins were estimated.
Results Table I summarizes the results of the agglutination tests using the somatic "O" and the flagellar "H" agglutinogens. As regards the "O" agglutinin, it will be noted that the greater percentage of subjects with the higher titers are in the group vaccinated intradermally. This becomes more evident in the results obtained after 13 months. Thus, at this time, in the intradermal group over three times as many individuals show a titer of 1: 40 or better as are found Similarly, the group inoculated intradermally shows a significantly larger percentage of higher titer values for the "H" agglutinin. However, there is no significant difference between the two groups as to the rapidity in which this agglutinin is no longer demonstrable. In both groups, the "H" agglutinin is present in the greater percentage of cases and to a greater degree than is the "O" agglutinin.
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In Table 2 the data are analyzed so as to indicate in both the intradermal and subcutaneous groups (a) those individuals that have both agglutinins present, (b) those individuals that have only the "O" agglutinin, (c) those that have only the "H" agglutinin present, and (d) those individuals in whom neither agglutinin is demonstrable. Of the individuals that have both agglutinins, the subcutaneous group shows a higher percentage of positive reactors at the end of 50 days, but by the end of 5 months there no longer is any significant difference, and by the end of 13 months the reverse is true. This apparent difference between the two groups is almost entirely due to the loss of the "O" agglutinin reactors in the subcutaneous group, whereas the "O" reactors in the intradermal group remain quite constant throughout the study. The presence of the "H" or "O" agglutinin alone is compared in each group. When one of the two agglutinins is no longer demonstrable, the "O" agglutinin is the one that is always lost in the subcutaneous group; the same is true for the intradermal group with the exception of 3 cases (8.1 per cent) at the end of 13 months.
About 97 per cent of both groups retain at least one of the agglutinins (the "H" agglutinin) for at least 5 months, but by the end of 13 months about 22 per cent of each group have lost both agglutinins. This finding is in agreement with Perry,4 who found that about 25 per cent of his cases had lost both agglutinins at the 611 end of one year. Longfellow and Luippold3 and Siler and Dunham5 found that about 20 per cent of their cases had theoretically inadequate levels of mouse protection antibodies at from 12 to 18 months after vaccination.
Reactions
Because of the relatively small number of cases, a comparison of the reactions in the two groups has little statistical significance. Two children in the group inoculated intradermally had a temperature of approximately 1000 F., which lasted less than 12 hours, with associated malaise and marked redness and induration at the site of inoculation. In the group inoculated subcutaneously, there were four children that reacted with fever (1000 F. or higher), general malaise, and pain and swelling at the site of inoculation.
Up to the present time, well over 1000 individuals of all ages have been vaccinated intradermally. There were only two relatively severe systemic reactions in addition to the cases noted above. In both cases the site of inoculation showed an area of redness and induration measuring about 10 cm. in diameter. There was evidence of lymphangitis as well as enlargement and tenderness of the axillary and epitrochlear glands. Both cases (adults) showed an elevated temperature, about 1010 F., which subsided in 24 hours. General malaise with local swelling and pain was noted in somewhat less than two per cent of the cases. This was almost entirely confined to the adult population, and is a significantly lower incidence of reactions than result from the usual subcutaneous vaccinations against typhoid. Van Gelder and Fisher10 recently reported on approximately 600 children, half of whom received intradermal inoculations, the remainder, subcutaneous. They found a reaction rate of 17 per cent in the subcutaneous group as compared to 3 per cent in the intradermal group.
Discussion
There is no adequately tested procedure for estimating immunity to typhoid fever. The two methods now in common use, namely, the determination of specific agglutinin titers and the mouse protection test must be considered as primarily measures of the presence of specific humoral antibody responses whose relationship to immu-nity is still to be defined. While the mouse protection test would appear to offer more tangible evidence of a possible immunity than does the study of agglutinins, it has many practical limitations for most laboratories. Unfortunately, there are no available data in the literature comparing simultaneous studies of "O0" and "H" agglutinin titers with mouse protection tests. It is apparent, therefore, that the complete interpretation of data such as were obtained in this study cannot be offered.
However, the fact that the intradermal method of immunization can give rise to a greater immunogenic response than does the subcutaneous method is of importance. Our data are in essential agreement with others in this respect.4' 889 It has also been demonstrated that the intradermal method of immunization gives as good a response (possibly a better one) in the development of mouse protective antibodies, both following revaccination3i 5 and after the initial vaccination. 8 Finally, it should be noted that the intradermal method requires but one-tenth the quantity of vaccine usually given by the subcutaneous route. The estimated cost of a three-dose course is 1.2 cents for the intradermal method as compared to 12 cents for the subcutaneous method. In addition, where large numbers are being vaccinated, much time can be saved with the intradermal method by using the same syringe and needle, with proper aseptic technic, for a relatively large number of individuals.
Summary and conclusions (1) The results of a comparative study of the intradermal and subcutaneous methods for anti-typhoid vaccination are described.
(2) On the basis of the immunogenic response, the nature and frequency of reactions, and the cost in materials and time, the intradermal method is believed to be the preferable one.
